Raleigh Capital Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-35
Closed -$8.94K – 779
2024
Q4
$8.94K Sell
35
-43
-55% -$11.5K ﹤0.01% 620
2024
Q3
$24.8K Sell
78
-18
-19% -$6.41K 0.01% 414
2024
Q2
$35.9K Buy
96
+57
+146% +$19.2K 0.02% 344
2024
Q1
$13.6K Buy
39
+12
+44% +$4.55K 0.01% 493
2023
Q4
$12.6K Buy
27
+7
+35% +$3.45K 0.01% 534
2023
Q3
$9.93K Buy
20
+5
+33% +$2.35K 0.01% 525
2023
Q2
$6.72K Sell
15
-7
-32% -$3.52K ﹤0.01% 571
2023
Q1
$10.7K Buy
22
+16
+267% +$7.91K 0.01% 487
2022
Q4
$3.07K Hold
6
– – ﹤0.01% 628
2022
Q3
$3K Buy
+6
New +$2.92K ﹤0.01% 589

Other funds holding HUM

Raleigh Capital Management's HUM Position: Q1 2025 in Review

Raleigh Capital Management sold out of Humana (HUM) in Q1 2025, closing a stake of 35 shares — an estimated $8.94K sold.

Raleigh Capital Management first reported a position in HUM in Q3 2022 and held it in 10 quarters. The position peaked at $35.9K in Q2 2024. 903 funds tracked by Wall St. Rank hold HUM as of Q1 2025.

  • Raleigh Capital Management reported no remaining Humana position as of Q1 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 35 Humana shares in Q1 2025, an estimated $8.94K.
  • Raleigh Capital Management first reported a position in Humana in Q3 2022 and held it in 10 quarters.
  • Raleigh Capital Management's Humana position peaked at $35.9K in Q2 2024.
  • 903 funds tracked by Wall St. Rank held Humana as of Q1 2025.

Based on Raleigh Capital Management's 13F filing for Q1 2025, filed 29 Apr 2025.